Vasculitis of the central nervous system

Journal of Neurology

Volumn 245, Issue 12, 1998, Pages 766-776

  Ferro, José M ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Angiitis; Stroke; Vasculitis

Indexed keywords

AUTOANTIBODY; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

ANGIOGRAPHY; AORTA ARCH SYNDROME; BIOPSY; CENTRAL NERVOUS SYSTEM FUNCTION; CHURG STRAUSS SYNDROME; COLLAGEN DISEASE; DISEASE CLASSIFICATION; GIANT CELL ARTERITIS; HUMAN; LABORATORY TEST; MUCOCUTANEOUS LYMPH NODE SYNDROME; NERVE INJURY; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYARTERITIS NODOSA; PRIORITY JOURNAL; REVIEW; SCREENING; STROKE; VASCULITIS; WEGENER GRANULOMATOSIS;

BRAIN; CEREBROVASCULAR DISORDERS; HUMANS; VASCULITIS;

EID: 0031730073     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050285     Document Type: Review

References (84)

1. Adu D, Pall A, Luqmani RA, Richards NT, Howie AJ, Emery P, Michael J, Savage COS, Bacon PA (1997) Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. Q J Med 90:401-409
2. Aggarwal SK, Williams V, Leveine SR, Cassin BJ, Garcia JH (1996) Cocaine intracranial hemorrhage: absence of vasculitis in 14 cases. Neurology 46:1741-1743
3. Alexander E (1992) Central nervous system disease in Sjögren's syndrome. Rheum Dis Clin North Am 18:637-672
4. Alexander GE, Provost TT, Stevens MB, Alexander EL (1981) Sjögren syndrome: central nervous system manifestations. Neurology 31:1391-1396
5. Alhalabi M, Moore PM (1994) Serial angiography in isolated angiitis of the central nervous system. Neurology 44: 1221-1226
6. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lighfoot RW Jr, Masi AT, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology. 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129-1134
7. Averbuch-Heller L, Steiner I, Abramsky O (1992) Neurologic manifestations of progressive systemic sclerosis. Arch Neurol 49:11292-11295
8. Bloch DA, Michel BA, Hunder GG, McShane DJ, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Fries JF, Leavitt RY, Lie JT, Lightfoot RW Jr, Masi AT, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology. 1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum 33:1068-1073
9. Boman S, Ballen JL, Seggev JS (1995) Dramatic responses to intravenous immunoglobulin in vasculitis. J Intern Med 238:375-377
10. Bousser MG, Bletry O, Launay M, Portier E, Guillard A, Castaigne P (1980) Thromboses veineuses cérébrales au cours de la maladie de Behçet. Rev Neurol (Paris) 136:753-762
11. Brack A, Geisler A, Martineztaboada VM, Younge BR, Goronzy JJ, Weyand CM (1997) Giant cell vasculitis is a T cell-dependent disease. Mol Med 3: 530-543
12. Canhão P, Ferro JM, Freitas JP (1992) Manifestações neurológicas na doença de Behçet. Revisão de casuística dos Serviços de Neurologia e Dermatologia do Hospital de Santa Maria. Acta Med Port 5:369-371
13. Caselli RJ, Hunder GG, Whisnant JP (1988) Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 38:352-359
14. Çomu S, Verstraeten T, Rinkoff JS, Busis NA (1996) Neurological manifestations of acute posterior multifocal placoid pigment epitheliopathy. Stroke 27:996-1001
15. Daras M, Tuchman AJ, Koppel BS, Samkoff LM, Weitzner I, Marc J (1994) Neurovascular complications of cocaine. Acta Neurol Scand 90:124-129
16. Devinsky O, Petito CK, Alonso DR (1988) Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 23:380-384
17. Duna GF, Calabrese LH (1995) Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system. J Rheumatol 22: 662-667
18. Easton JD (1995) The temporal arteritis dilemmas. Cerebrovasc Dis 5:369-374
19. Ehsan T, Hasan S, Powers JM, Heiserman JE (1995) Serial magnetic resonance imaging in isolated angiitis of the central nervous system. Neurology 45:1462-1465
20. Eichhorn J, Sima D, Thiele B, Lindschau C, Turowski A, Schmidt H, Schneider W, Haller H, Luft FC (1996) Anti-endothelial cell antibodies in Takayasu arteritis. Circulation 94: 2396-2401
21. Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage COS, Adu D (1997) Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 40:371-380
22. Ferro JM, Crespo M (1988) Young adult stroke: neuropsychological dysfunction and recovery. Stroke 19:982-986
23. Ferro JM, Crespo M (1994) Prognosis after transient ischemic attacks and ischemic stroke in young adults. Stroke 25:1611-1616
24. Font C, Cid MC, Collvinent B, Lopezsoto A, Grau JM (1997) Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Br J Rheumatol 36:251-254
25. Futrell N (1995) Inflammatory vascular disorders: diagnosis and treatment in ischemic stroke. Curr Opin Neurol 8: 55-61
26. Futrell N, Millikan C (1989) Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke 20:583-591
27. Gilad R, Lampl Y, Eshel Y, Barak V, Sarovapinhas I (1997) Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus. Br J Rheumatol 36: 190-193
28. Gomezreino JJ (1995) Magnetic resonance imaging of the brain in systemic lupus erythematosus. Br J Rheumatol 34:1055-1060
29. Hang LM, Nakamura RM (1997) Current concepts and advances in clinical laboratory testing for autoimmune diseases. Crit Rev Clin Lab Sci 34:275-311
30. Hankey GJ (1991) Isolated angiitis/angiopathy of the central nervous system. Cerebrovasc Dis 12-15
31. Harris KG, Tran DD, Sickels WJ, Cornell SH, Yuh WTC (1994) Diagnosing intracranial vasculitis: the role of MR and angiography. Am J Neuroradiol 15:317-330
32. Hart RG, Miller VT, Coull BM, Bril V (1984) Cerebral infarction associated with lupus anticoagulants - preliminary report. Stroke 15:114-118
33. Hietaharju A, Jääskeläinen S, Hietarinta M, Frey H (1993) Central nervous system involvement and psychiatric manifestations in systemic sclerosis (scleroderma): clinical and neurophysiological evaluation. Acta Neurol Scand 87:382-387
34. Hoffman GS (1995) Treatment of resistant Takayasu's arteritis. Rheum Dis Clin North Am 21:73-80
35. Hunder GG, Arend WP, Block DA, Calabrese LH, Fauci AS, Fries JF, Leavitt RY, Lie JT, Lightfoot RW Jr, Masi AT, McShane DJ, Michel BA, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American Collage of Rheumatology. 1990 criteria for the classification of vasculitis: introduction. Arthritis Rheum 33:1065-1067
36. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr, Masi AT, McShane DJ, Mills JA, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology. 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122-1128
37. Ishida K, Kamata T, Tsukagoshi H, Tanizaki Y (1993) Progressive systemic sclerosis with CNS vasculitis and cyclosporin A therapy. J Neurol Neurosurg Psychiatry 56:720-723
38. Jayne DRW, Rasmussen N, for the European Community Systemic Vasculitis Clinical Trials Study Group (EC-SYSVASTRIAL) (1997) Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group. Mayo Clin Proc 72:737-747
39. Jeanette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, Es LA van, Waldherr R, Wiik A (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187-192
40. Kallenberg COM (1997) Laboratory findings in the vasculitides. Baillieres Clin Rheumatol 11:395-421
41. Kattah JC, Chrousos GA, Katz PA, McCasland B, Kolsky MP (1994) Anterior ischemic optic neuropathy in Churg-Strauss syndrome. Neurology 44:2200-2202
42. Kawi MZ al, Bohlege S, Banna M (1991) MRI finding in neuro-Behçet's disease. Neurology 41:405-408
43. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120:919-929
44. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV (1995) The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 332:993-997
45. Kitagawa Y, Gotoh F, Koto A, Okayasu H (1990) Stroke in systemic-lupus erythematosus. Stroke 21:1533-1539
46. Kokkinos J, Levine SR (1993) Stroke. In: Brust JCM (ed) Neurologic complications of drug and alcohol abuse. (Neurol Clin vol 11) Saunders, Philadelphia, pp 577-590
47. Levine SR, Brust JCM, Futreli N, Ho KL, Blake D, Millikian CH, Brass LM, Fayad P, Schultz LR, Selwa JF, Welch KMA (1990) Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine. N Engl J Med 323:699-704
48. Lie JT (1997) Biopsy diagnosis of systemic vasculitis. Baillieres Clin Rheumatol 11:219-236
49. Lie JT (1994) Nomenclature and classification of vasculitis: plus ça change, plus c'est la même chose. Arthritis Rheum 37:181-186
50. Liou HH, Liu HM, Chiang IP, Yeh TS, Chen RC (1997) Churg-Strauss syndrome presented as multiple intracerebral hemorrhage. Lupus 6:279-282
51. Lockwood CM (1996) New treatment strategies for systemic vasculitis: the role of intravenous immune globulin therapy. Clin Exp Immunol 104:77-82
52. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emergy P, Savage C, Adu D (1994) Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. Q J Med 87: 671-678
53. Mandybur TI (1979) Cerebral amyloid angiopathy: possible relationship to rheumatoid vasculitis. Neurology 29: 1336-1340
54. Mevorach D, Goldberg Y, Gomori JM, Rachmilewitz D (1996) Antiphospholipid syndrome manifested by ischemic stroke in a patient with Crohn's disease. J Clin Gastroenterol 22:141-143
55. Miller DH, Ormerod IEC, Gibson A, Boulay EPGH du, Rudge P, McDonald WI (1987) MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis. Neuroradiology 29:226-231
56. Mitsias P, Levine SR (1994) Large cerebral vessel occlusive disease in systemic lupus erythematosus. Neurology 44:385-393
57. Montalbán J, Rio J, Khumustha M, Davalos A, Codina M, Swana GT, Calcagnotto ME, Sumalla J, Mederer S, Gil A, Hughes GRV, Codina A (1994) Value of immunologic testing in stroke patients. A prospective multicenter study. Stroke 25:2412-2415
58. Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE (1993) Neurological involvement in Wegener's grunulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 33:4-9
59. Nolte KB, Brass LM, Fletterick CF (1996) Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology 46:1291-1296
60. Oliveira V, Póvoa P, Costa A, Ducla-Soares J (1994) Cerebrospinal fluid and therapy of isolated angiitis of the central nervous system. Stroke 25: 1693-1695
61. Ostrov BE, Barron TF (1995) Cerebral vasculitis. Diagnosis and current treatment recommendations. CNS Drugs 3: 115-125
62. Pascual J, Berciano J (1994) Experince in the diagnosis of headaches that start in elderly people. J Neurol Neurosurg Psychiatry 57:1255-1257
63. Pathak R, Gabor AJ (1991) Scleroderma and central nervous system vasculitis. Stroke 22:410-413
64. Petri M, Roubenoff R, Dallal GE, Nadeau MR, Selhub J, Rosenberg IR (1996) Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 348:1120-1124
65. Provenzale JM, Allen NB (1996) Neuroradiologic findings in polyarteritis nodosa. AJNR Am J Neuroradiol 17: 1119-1126
66. Provenzale JM, Allen NB (1996) Wegener granulomalosis - CT and MR findings. AJNR Am J Neuroradiol 17: 785-792
67. Qureshi AI, Akbar MS, Czander E, Safdar K, Janssen RS, Frankel MR (1997) Crack cocaine use and stroke in young patients. Neurology 48:341-345
68. Roldan CA, Shively BK, Crawford MH (1996) An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 335:1424-1430
69. Rovang RD, Zawada ET, Santella RN, Jaqua RA, Boice JL, Welter RL (1997) Cerebral vasculitis associated with acute post-streptococcal glomerulonephritis. Am J Nephrol 17:89-92
70. Savage COS, Harper L, Adu D (1997) Primary systemic vasculitis. Lancet 349:553-558
71. Savitz JM, Young MA, Ratan RR (1994) Basilar artery occlusion in a young patient with Wegener's granulomatosis. Stroke 25:214-216
72. Sehgal M, Swanson JW, Deremee RA, Colby TV (1995) Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc 70:337-341
73. Sigal LH (1987) The neurologic presentation of vasculitic and rheumatologic syndromes. A review. Medicine 66:157-180
74. Sneller MC, Fauci AS (1997) Pathogenesis of vasculitis syndromes. Med Clin North Am 81:221-242
75. Spezialetti R, Bluestein HG, Peter JB, Alexander EL (1993) Neuropsychiatric disease in Sjögren's syndrome: anti-ribosomal P and anti-neuronal antibodies. Am J Med 95:153-160
76. Stewart SS, Ashizawa T, Dudley AW Jr, Goldberg JW, Lidsky MD (1988) Cerebral vasculitis in relapsing polychondritis. Neurology 38:150-152
77. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
78. The Antiphospholipid Antibodies and Stroke Study Group (APASS) (1993) Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology 43:2069-2073
79. The Antiphospholipid Antibodies and Stroke Study Group (APASS) (1997) Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death. Neurology 48:91-94
80. The WARSS, APASS, PICSS, HAS and GENESIS study groups (1997) The feasibility of a collaborative double-blind study using an anticoagulant: the warfarin-aspirin recurrent stroke study (WARSS), the antiphospholipid antibodies and stroke study (APASS), the patent foramen ovale in cryptogenic stroke study (PICSS), the hemostatic system activation study (HAS) and the genes in stroke study (GENESIS). Cerebrovasc Dis 7:100-112
81. Watts RA, Scott DGI (1997) Classification and epidemiology of vasculitis. Baillieres Clin Rheumatol 11:191-217
82. Watts RA, Carruthers DM, Scott DGI (1995) Epidemiology of systemic vasculitis - changing incidence or definition. Semin Arthritis Rheum 25:28-34
83. Wilkinson IMS, Russel RWR (1972) Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement. Arch Neurol 27:378-391
84. Yamada M, Itoh Y, Shintaku M, Kawamura J, Jensson O, Thorsteinsson L, Suematsu N, Matsushita M, Otomo E (1996) Immune reactions associated with cerebral amyloid angiopathy. Stroke 27:1155-1162